APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Livestock Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Research

Livestock Vaccines Industry Research Report 2026

Report ID 174008610526 December 2025134 pages

Choose your research edition.

Industry ResearchLivestock Vaccines Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Livestock Vaccines Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Livestock Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Livestock Vaccines Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Livestock Vaccines Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Livestock Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Livestock Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Livestock Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Livestock Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Livestock Vaccines include Boehringer Ingelheim, Ceva, Elanco, Harbin Pharmaceutical Group, Hester Biosciences, Hile, Japfa Comfeed Indonesia, JinYu Biotechnology and MEVAC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Livestock Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Livestock Vaccines Market by Company

Boehringer Ingelheim

Ceva

Elanco

Harbin Pharmaceutical Group

Hester Biosciences

Hile

Japfa Comfeed Indonesia

JinYu Biotechnology

MEVAC

Nisseiken

Phibro Animal Health Corporation

Pulike

QYH Biotech Co., Ltd

Vaxxinova®

Venky's

Zoetis

Merck

Livestock Vaccines Segment by Type

Foot and Mouth Disease Vaccine

Bird Flu Vaccine

Porcine Blue Ear Vaccine

Swine Fever Vaccine

Pig Ring Vaccine

Livestock Vaccines Segment by Application

Pig

Cattle and Sheep

Others

Livestock Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Livestock Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Livestock Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Livestock Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Livestock Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Livestock Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Livestock Vaccines Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Livestock Vaccines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Livestock Vaccines Revenue of Manufacturers (2021-2026) Table 9. Global Livestock Vaccines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Livestock Vaccines Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Livestock Vaccines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Livestock Vaccines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Livestock Vaccines, Product Type & Application Table 14. Global Livestock Vaccines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Livestock Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Boehringer Ingelheim Company Information Table 19. Boehringer Ingelheim Business Overview Table 20. Boehringer Ingelheim Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Boehringer Ingelheim Livestock Vaccines Product Portfolio Table 22. Boehringer Ingelheim Recent Developments Table 23. Ceva Company Information Table 24. Ceva Business Overview Table 25. Ceva Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Ceva Livestock Vaccines Product Portfolio Table 27. Ceva Recent Developments Table 28. Elanco Company Information Table 29. Elanco Business Overview Table 30. Elanco Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Elanco Livestock Vaccines Product Portfolio Table 32. Elanco Recent Developments Table 33. Harbin Pharmaceutical Group Company Information Table 34. Harbin Pharmaceutical Group Business Overview Table 35. Harbin Pharmaceutical Group Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Harbin Pharmaceutical Group Livestock Vaccines Product Portfolio Table 37. Harbin Pharmaceutical Group Recent Developments Table 38. Hester Biosciences Company Information Table 39. Hester Biosciences Business Overview Table 40. Hester Biosciences Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hester Biosciences Livestock Vaccines Product Portfolio Table 42. Hester Biosciences Recent Developments Table 43. Hile Company Information Table 44. Hile Business Overview Table 45. Hile Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Hile Livestock Vaccines Product Portfolio Table 47. Hile Recent Developments Table 48. Japfa Comfeed Indonesia Company Information Table 49. Japfa Comfeed Indonesia Business Overview Table 50. Japfa Comfeed Indonesia Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Japfa Comfeed Indonesia Livestock Vaccines Product Portfolio Table 52. Japfa Comfeed Indonesia Recent Developments Table 53. JinYu Biotechnology Company Information Table 54. JinYu Biotechnology Business Overview Table 55. JinYu Biotechnology Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. JinYu Biotechnology Livestock Vaccines Product Portfolio Table 57. JinYu Biotechnology Recent Developments Table 58. MEVAC Company Information Table 59. MEVAC Business Overview Table 60. MEVAC Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. MEVAC Livestock Vaccines Product Portfolio Table 62. MEVAC Recent Developments Table 63. Nisseiken Company Information Table 64. Nisseiken Business Overview Table 65. Nisseiken Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Nisseiken Livestock Vaccines Product Portfolio Table 67. Nisseiken Recent Developments Table 68. Phibro Animal Health Corporation Company Information Table 69. Phibro Animal Health Corporation Business Overview Table 70. Phibro Animal Health Corporation Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Phibro Animal Health Corporation Livestock Vaccines Product Portfolio Table 72. Phibro Animal Health Corporation Recent Developments Table 73. Pulike Company Information Table 74. Pulike Business Overview Table 75. Pulike Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Pulike Livestock Vaccines Product Portfolio Table 77. Pulike Recent Developments Table 78. QYH Biotech Co., Ltd Company Information Table 79. QYH Biotech Co., Ltd Business Overview Table 80. QYH Biotech Co., Ltd Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. QYH Biotech Co., Ltd Livestock Vaccines Product Portfolio Table 82. QYH Biotech Co., Ltd Recent Developments Table 83. Vaxxinova® Company Information Table 84. Vaxxinova® Business Overview Table 85. Vaxxinova® Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Vaxxinova® Livestock Vaccines Product Portfolio Table 87. Vaxxinova® Recent Developments Table 88. Venky's Company Information Table 89. Venky's Business Overview Table 90. Venky's Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Venky's Livestock Vaccines Product Portfolio Table 92. Venky's Recent Developments Table 93. Zoetis Company Information Table 94. Zoetis Business Overview Table 95. Zoetis Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Zoetis Livestock Vaccines Product Portfolio Table 97. Zoetis Recent Developments Table 98. Merck Company Information Table 99. Merck Business Overview Table 100. Merck Livestock Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Merck Livestock Vaccines Product Portfolio Table 102. Merck Recent Developments Table 103. Global Livestock Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Livestock Vaccines Sales by Region (2021-2026) & (K Units) Table 105. Global Livestock Vaccines Sales Market Share by Region (2021-2026) Table 106. Global Livestock Vaccines Sales by Region (2027-2032) & (K Units) Table 107. Global Livestock Vaccines Sales Market Share by Region (2027-2032) Table 108. Global Livestock Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Livestock Vaccines Revenue Market Share by Region (2021-2026) Table 110. Global Livestock Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Livestock Vaccines Revenue Market Share by Region (2027-2032) Table 112. North America Livestock Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Livestock Vaccines Sales by Country (2021-2026) & (K Units) Table 114. North America Livestock Vaccines Sales by Country (2027-2032) & (K Units) Table 115. North America Livestock Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Livestock Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Livestock Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Livestock Vaccines Sales by Country (2021-2026) & (K Units) Table 119. Europe Livestock Vaccines Sales by Country (2027-2032) & (K Units) Table 120. Europe Livestock Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Livestock Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Livestock Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Livestock Vaccines Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Livestock Vaccines Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Livestock Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Livestock Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Livestock Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Livestock Vaccines Sales by Country (2021-2026) & (K Units) Table 129. South America Livestock Vaccines Sales by Country (2027-2032) & (K Units) Table 130. South America Livestock Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Livestock Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Livestock Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Livestock Vaccines Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Livestock Vaccines Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Livestock Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Livestock Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Livestock Vaccines Sales by Type (2021-2026) & (K Units) Table 138. Global Livestock Vaccines Sales by Type (2027-2032) & (K Units) Table 139. Global Livestock Vaccines Sales Market Share by Type (2021-2026) Table 140. Global Livestock Vaccines Sales Market Share by Type (2027-2032) Table 141. Global Livestock Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Livestock Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Livestock Vaccines Revenue Market Share by Type (2021-2026) Table 144. Global Livestock Vaccines Revenue Market Share by Type (2027-2032) Table 145. Global Livestock Vaccines Price by Type (2021-2026) & (US$/Unit) Table 146. Global Livestock Vaccines Price by Type (2027-2032) & (US$/Unit) Table 147. Global Livestock Vaccines Sales by Application (2021-2026) & (K Units) Table 148. Global Livestock Vaccines Sales by Application (2027-2032) & (K Units) Table 149. Global Livestock Vaccines Sales Market Share by Application (2021-2026) Table 150. Global Livestock Vaccines Sales Market Share by Application (2027-2032) Table 151. Global Livestock Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Livestock Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Livestock Vaccines Revenue Market Share by Application (2021-2026) Table 154. Global Livestock Vaccines Revenue Market Share by Application (2027-2032) Table 155. Global Livestock Vaccines Price by Application (2021-2026) & (US$/Unit) Table 156. Global Livestock Vaccines Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Livestock Vaccines Distributors List Table 160. Livestock Vaccines Customers List Table 161. Livestock Vaccines Industry Trends Table 162. Livestock Vaccines Industry Drivers Table 163. Livestock Vaccines Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Livestock Vaccines Product Image Figure 5. Global Livestock Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Livestock Vaccines Market Size (2021-2032) & (US$ Million) Figure 7. Global Livestock Vaccines Sales (2021-2032) & (K Units) Figure 8. Global Livestock Vaccines Average Price (US$/Unit) & (2021-2032) Figure 9. Foot and Mouth Disease Vaccine Product Image Figure 10. Bird Flu Vaccine Product Image Figure 11. Porcine Blue Ear Vaccine Product Image Figure 12. Swine Fever Vaccine Product Image Figure 13. Pig Ring Vaccine Product Image Figure 14. Pig Product Image Figure 15. Cattle and Sheep Product Image Figure 16. Others Product Image Figure 17. Global Livestock Vaccines Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Livestock Vaccines, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Livestock Vaccines Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Livestock Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Livestock Vaccines Sales by Region in 2025 Figure 23. Global Livestock Vaccines Revenue by Region in 2025 Figure 24. North America Livestock Vaccines Market Size by Country in 2025 Figure 25. North America Livestock Vaccines Sales Market Share by Country (2021-2032) Figure 26. North America Livestock Vaccines Revenue Market Share by Country (2021-2032) Figure 27. United States Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Livestock Vaccines Market Size by Country in 2025 Figure 31. Europe Livestock Vaccines Sales Market Share by Country (2021-2032) Figure 32. Europe Livestock Vaccines Revenue Market Share by Country (2021-2032) Figure 33. Germany Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Livestock Vaccines Market Size by Country in 2025 Figure 44. Asia Pacific Livestock Vaccines Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Livestock Vaccines Revenue Market Share by Country (2021-2032) Figure 46. China Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Livestock Vaccines Market Size by Country in 2025 Figure 55. South America Livestock Vaccines Sales Market Share by Country (2021-2032) Figure 56. South America Livestock Vaccines Revenue Market Share by Country (2021-2032) Figure 57. Brazil Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Livestock Vaccines Market Size by Country in 2025 Figure 61. Middle East and Africa Livestock Vaccines Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Livestock Vaccines Revenue Market Share by Country (2021-2032) Figure 63. Egypt Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Livestock Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Livestock Vaccines Sales Market Share by Type (2021-2032) Figure 69. Global Livestock Vaccines Revenue Market Share by Type (2021-2032) Figure 70. Global Livestock Vaccines Price (US$/Unit) by Type (2021-2032) Figure 71. Global Livestock Vaccines Sales Market Share by Application (2021-2032) Figure 72. Global Livestock Vaccines Revenue Market Share by Application (2021-2032) Figure 73. Global Livestock Vaccines Price (US$/Unit) by Application (2021-2032) Figure 74. Livestock Vaccines Value Chain Figure 75. Livestock Vaccines Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Livestock Vaccines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Foot and Mouth Disease Vaccine
  • Bird Flu Vaccine
  • Porcine Blue Ear Vaccine
  • Swine Fever Vaccine
  • Pig Ring Vaccine
Applications
  • Pig
  • Cattle and Sheep
  • Others
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Elanco
  • Harbin Pharmaceutical Group
  • Hester Biosciences
  • Hile
  • Japfa Comfeed Indonesia
  • JinYu Biotechnology
  • MEVAC
  • Nisseiken
  • Phibro Animal Health Corporation
  • Pulike
  • QYH Biotech Co., Ltd
  • Vaxxinova®
  • Venky's
  • Zoetis
  • Merck

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Livestock Vaccines Market Size (2021-2032)
  4. 2.2.2 Global Livestock Vaccines Sales (2021-2032)
  5. 2.2.3 Global Livestock Vaccines Market Average Price (2021-2032)
  6. 2.3 Livestock Vaccines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Foot and Mouth Disease Vaccine
  9. 2.3.3 Bird Flu Vaccine
  10. 2.3.4 Porcine Blue Ear Vaccine
  11. 2.3.5 Swine Fever Vaccine
  12. 2.3.6 Pig Ring Vaccine
  13. 2.4 Livestock Vaccines by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Pig
  16. 2.4.3 Cattle and Sheep
  17. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Livestock Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Livestock Vaccines Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Livestock Vaccines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Livestock Vaccines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Livestock Vaccines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Livestock Vaccines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Livestock Vaccines, Product Type & Application
  8. 3.8 Global Manufacturers of Livestock Vaccines, Established Date
  9. 3.9 Global Livestock Vaccines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Boehringer Ingelheim
  2. 4.1.1 Boehringer Ingelheim Company Information
  3. 4.1.2 Boehringer Ingelheim Business Overview
  4. 4.1.3 Boehringer Ingelheim Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Boehringer Ingelheim Livestock Vaccines Product Portfolio
  6. 4.1.5 Boehringer Ingelheim Recent Developments
  7. 4.2 Ceva
  8. 4.2.1 Ceva Company Information
  9. 4.2.2 Ceva Business Overview
  10. 4.2.3 Ceva Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Ceva Livestock Vaccines Product Portfolio
  12. 4.2.5 Ceva Recent Developments
  13. 4.3 Elanco
  14. 4.3.1 Elanco Company Information
  15. 4.3.2 Elanco Business Overview
  16. 4.3.3 Elanco Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Elanco Livestock Vaccines Product Portfolio
  18. 4.3.5 Elanco Recent Developments
  19. 4.4 Harbin Pharmaceutical Group
  20. 4.4.1 Harbin Pharmaceutical Group Company Information
  21. 4.4.2 Harbin Pharmaceutical Group Business Overview
  22. 4.4.3 Harbin Pharmaceutical Group Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Harbin Pharmaceutical Group Livestock Vaccines Product Portfolio
  24. 4.4.5 Harbin Pharmaceutical Group Recent Developments
  25. 4.5 Hester Biosciences
  26. 4.5.1 Hester Biosciences Company Information
  27. 4.5.2 Hester Biosciences Business Overview
  28. 4.5.3 Hester Biosciences Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hester Biosciences Livestock Vaccines Product Portfolio
  30. 4.5.5 Hester Biosciences Recent Developments
  31. 4.6 Hile
  32. 4.6.1 Hile Company Information
  33. 4.6.2 Hile Business Overview
  34. 4.6.3 Hile Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Hile Livestock Vaccines Product Portfolio
  36. 4.6.5 Hile Recent Developments
  37. 4.7 Japfa Comfeed Indonesia
  38. 4.7.1 Japfa Comfeed Indonesia Company Information
  39. 4.7.2 Japfa Comfeed Indonesia Business Overview
  40. 4.7.3 Japfa Comfeed Indonesia Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Japfa Comfeed Indonesia Livestock Vaccines Product Portfolio
  42. 4.7.5 Japfa Comfeed Indonesia Recent Developments
  43. 4.8 JinYu Biotechnology
  44. 4.8.1 JinYu Biotechnology Company Information
  45. 4.8.2 JinYu Biotechnology Business Overview
  46. 4.8.3 JinYu Biotechnology Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 JinYu Biotechnology Livestock Vaccines Product Portfolio
  48. 4.8.5 JinYu Biotechnology Recent Developments
  49. 4.9 MEVAC
  50. 4.9.1 MEVAC Company Information
  51. 4.9.2 MEVAC Business Overview
  52. 4.9.3 MEVAC Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 MEVAC Livestock Vaccines Product Portfolio
  54. 4.9.5 MEVAC Recent Developments
  55. 4.10 Nisseiken
  56. 4.10.1 Nisseiken Company Information
  57. 4.10.2 Nisseiken Business Overview
  58. 4.10.3 Nisseiken Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Nisseiken Livestock Vaccines Product Portfolio
  60. 4.10.5 Nisseiken Recent Developments
  61. 4.11 Phibro Animal Health Corporation
  62. 4.11.1 Phibro Animal Health Corporation Company Information
  63. 4.11.2 Phibro Animal Health Corporation Business Overview
  64. 4.11.3 Phibro Animal Health Corporation Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Phibro Animal Health Corporation Livestock Vaccines Product Portfolio
  66. 4.11.5 Phibro Animal Health Corporation Recent Developments
  67. 4.12 Pulike
  68. 4.12.1 Pulike Company Information
  69. 4.12.2 Pulike Business Overview
  70. 4.12.3 Pulike Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Pulike Livestock Vaccines Product Portfolio
  72. 4.12.5 Pulike Recent Developments
  73. 4.13 QYH Biotech Co., Ltd
  74. 4.13.1 QYH Biotech Co., Ltd Company Information
  75. 4.13.2 QYH Biotech Co., Ltd Business Overview
  76. 4.13.3 QYH Biotech Co., Ltd Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 QYH Biotech Co., Ltd Livestock Vaccines Product Portfolio
  78. 4.13.5 QYH Biotech Co., Ltd Recent Developments
  79. 4.14 Vaxxinova®
  80. 4.14.1 Vaxxinova® Company Information
  81. 4.14.2 Vaxxinova® Business Overview
  82. 4.14.3 Vaxxinova® Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Vaxxinova® Livestock Vaccines Product Portfolio
  84. 4.14.5 Vaxxinova® Recent Developments
  85. 4.15 Venky's
  86. 4.15.1 Venky's Company Information
  87. 4.15.2 Venky's Business Overview
  88. 4.15.3 Venky's Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Venky's Livestock Vaccines Product Portfolio
  90. 4.15.5 Venky's Recent Developments
  91. 4.16 Zoetis
  92. 4.16.1 Zoetis Company Information
  93. 4.16.2 Zoetis Business Overview
  94. 4.16.3 Zoetis Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Zoetis Livestock Vaccines Product Portfolio
  96. 4.16.5 Zoetis Recent Developments
  97. 4.17 Merck
  98. 4.17.1 Merck Company Information
  99. 4.17.2 Merck Business Overview
  100. 4.17.3 Merck Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Merck Livestock Vaccines Product Portfolio
  102. 4.17.5 Merck Recent Developments
5 Global Livestock Vaccines Market Scenario by Region
  1. 5.1 Global Livestock Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Livestock Vaccines Sales by Region: 2021-2032
  3. 5.2.1 Global Livestock Vaccines Sales by Region: 2021-2026
  4. 5.2.2 Global Livestock Vaccines Sales by Region: 2027-2032
  5. 5.3 Global Livestock Vaccines Revenue by Region: 2021-2032
  6. 5.3.1 Global Livestock Vaccines Revenue by Region: 2021-2026
  7. 5.3.2 Global Livestock Vaccines Revenue by Region: 2027-2032
  8. 5.4 North America Livestock Vaccines Market Facts & Figures by Country
  9. 5.4.1 North America Livestock Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Livestock Vaccines Sales by Country (2021-2032)
  11. 5.4.3 North America Livestock Vaccines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Livestock Vaccines Market Facts & Figures by Country
  16. 5.5.1 Europe Livestock Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Livestock Vaccines Sales by Country (2021-2032)
  18. 5.5.3 Europe Livestock Vaccines Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Livestock Vaccines Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Livestock Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Livestock Vaccines Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Livestock Vaccines Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Livestock Vaccines Market Facts & Figures by Country
  41. 5.7.1 South America Livestock Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Livestock Vaccines Sales by Country (2021-2032)
  43. 5.7.3 South America Livestock Vaccines Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Livestock Vaccines Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Livestock Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Livestock Vaccines Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Livestock Vaccines Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Livestock Vaccines Sales by Type (2021-2032)
  2. 6.1.1 Global Livestock Vaccines Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Livestock Vaccines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Livestock Vaccines Revenue by Type (2021-2032)
  5. 6.2.1 Global Livestock Vaccines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Livestock Vaccines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Livestock Vaccines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Livestock Vaccines Sales by Application (2021-2032)
  2. 7.1.1 Global Livestock Vaccines Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Livestock Vaccines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Livestock Vaccines Revenue by Application (2021-2032)
  5. 7.2.1 Global Livestock Vaccines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Livestock Vaccines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Livestock Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Livestock Vaccines Value Chain Analysis
  2. 8.1.1 Livestock Vaccines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Livestock Vaccines Production Mode & Process
  5. 8.2 Livestock Vaccines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Livestock Vaccines Distributors
  8. 8.2.3 Livestock Vaccines Customers
9 Global Livestock Vaccines Analyzing Market Dynamics
  1. 9.1 Livestock Vaccines Industry Trends
  2. 9.2 Livestock Vaccines Industry Drivers
  3. 9.3 Livestock Vaccines Industry Opportunities and Challenges
  4. 9.4 Livestock Vaccines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst